48 results
Page 2 of 3
6-K
EX-99.1
nymn190s d7l42346hqy
9 Feb 21
SciSparc Initiates Commercial Production of its CannAmide™ Pills
8:36am
6-K
EX-99.1
8ujxwjwoupoj tah
5 Jan 21
Therapix Biosciences and Cyntar Ventures Entered a Non-Binding Letter of Intent for the Distribution of TheraPEA in Canada
9:12am
424B4
2yoa en1dy5h
20 Nov 20
Prospectus supplement with pricing info
4:43pm
FWP
9yvez4z
5 Nov 20
Free writing prospectus
5:11pm
F-1/A
n8p8wt49i
4 Nov 20
Registration statement (foreign) (amended)
2:14pm
FWP
yef6 bjtdgh42fmmorxo
21 Oct 20
Free writing prospectus
7:26am
F-1/A
8bvteqi1 27yn7gk
20 Oct 20
Registration statement (foreign) (amended)
9:57pm
6-K
EX-99.2
1zwggdz qo89
9 Oct 20
Interim Consolidated Financial Statements
12:00am
F-1/A
p7ytj01
9 Oct 20
Registration statement (foreign) (amended)
12:00am
6-K
EX-99.1
f3miel kf6f
16 Sep 20
Developing cannabinoid based pharmaceuticals Corporate Presentation • September 2020
7:11am
F-1
wff0mm30s9kz00wg 8ox
8 Sep 20
Registration statement (foreign)
5:31pm
6-K
EX-99.2
q7tr09ldmv7sd5e he6
22 Apr 20
Therapix Biosciences Announces Appointment of New CEO
5:30pm
424B4
2u9oek ncwzx
2 Apr 20
Prospectus supplement with pricing info
5:28pm
F-1/A
4qet0s5tr4yq
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
hv52fm la
30 Mar 20
Registration statement (foreign) (amended)
12:29pm
F-1/A
iomag
26 Mar 20
Registration statement (foreign) (amended)
12:00am
F-1/A
9hdml4m29 3iu8t
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
424B5
07e61f6ph8rq8mfeb
5 Dec 19
Prospectus supplement for primary offering
5:29pm
6-K
EX-99.1
7evs6f4u y2z6u17x3n
31 Jul 19
Therapix Biosciences Announces Canadian Product License Issuance for TheraPEA (CannAmide™), a Non-Opiate Based Pain Management Supplement
4:03pm